HARVARD BIOSCIENCE, INC. (HBIO) Total liabilities 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) total liabilities at each fiscal year-end, per SEC filings.
$66.3MFY2025 · since FY2016: $35.6M → $66.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.3M | +4.8% |
| FY2024 | $63.3M | -1.5% |
| FY2023 | $64.3M | -12.1% |
| FY2022 | $73.1M | -7.4% |
| FY2021 | $78.9M | -0.8% |
| FY2020 | $79.6M | -4.3% |
| FY2019 | $83.2M | -3.2% |
| FY2018 | $85.9M | +201.9% |
| FY2017 | $28.5M | -20.0% |
| FY2016 | $35.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice